Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28073064 | 0.86 | LMNA (0.42) | LMNAPDE4AL3MBTL1TDP1 | |
| SCHEMBL7019182 | 0.86 | LMNA (0.42) | LMNAPDE4AL3MBTL1TDP1 | |
| SCHEMBL27277190 | 0.85 | PDE4A (0.48) | LMNAPDE4AL3MBTL1TDP1 | |
| SCHEMBL8889910 | 0.85 | PDE4A (0.48) | LMNAPDE4AL3MBTL1TDP1 | |
| SCHEMBL9517613 | 0.77 | GRIK1 (0.30) | — | |
| SCHEMBL10594780 | 0.77 | LMNA (0.38) | LMNAPDE4AL3MBTL1TDP1 | |
| SCHEMBL23294035 | 0.76 | LMNA (0.33) | LMNAL3MBTL1TDP1 | |
| SCHEMBL5598165 | 0.75 | — | — | |
| SCHEMBL30444755 | 0.75 | — | — | |
| Water SCHEMBL27476748 | 0.73 | OR51E2 (0.42) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210345602-A1 | MAMMAL CELL PRESERVING SOLUTION CONTAINING ACARBOSE OR STACHYOSE | OTSUKA PHARMACEUTICAL FACTORY, INC (JP) | 2021-11-11 | — | — | US | disclosed |
| EP-3858975-A1 | MAMMAL CELL PRESERVING SOLUTION CONTAINING ACARBOSE OR STACHYOSE | Otsuka Pharmaceutical Factory, Inc. (JP) | 2021-08-04 | — | — | EP | disclosed |
| CN-109336887-A | A kind of benzimidazole and chiral heterocycle class compound and its preparation method and application | 中山大学 | 2019-02-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210345602-A1 | MAMMAL CELL PRESERVING SOLUTION CONTAINING ACARBOSE OR STACHYOSE | ASAH2, PIGS, TREH | LMNA 1709/4885PDE4A 3524/4885L3MBTL1 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.